Tuberculosis Vaccine
TB vaccine candidate gets up to $550 million in funding for phase 3 trial
Wellcome and the Bill & Melinda Gates Foundation announced Wednesday that they will provide up to $550 million in funding for a phase 3 trial of a tuberculosis vaccine candidate.
World TB Day: Is TB vaccine and treatment research back on track?
Throughout the COVID-19 pandemic, World TB Day, which is observed each year on March 23, has marked the need for more — more research, more testing, more treatment options, and more access for patients globally.
Q&A: Understanding challenges behind developing second TB vaccine
Currently, the Bacillus Calmette-Guérin vaccine from 1921 is the only available vaccine for tuberculosis, according to a press release from the European Society of Clinical Microbiology and Infectious Diseases.
People with HIV should participate in tuberculosis vaccine trials, new recommendations say
Experts say that people with HIV should be included in clinical trials for new tuberculosis vaccine candidates in the pipeline, according to newly written recommendations published in The Lancet HIV.